W Yk Chan1, A Wk Leung2, C W Luk3, R Ch Li4, A Sc Ling5, S Y Ha1. 1. Department of Paediatrics and Adolescent Medicine, Queen Mary Hospital, Pokfulam, Hong Kong. 2. Department of Paediatrics and Adolescent Medicine, Prince of Wales Hospital, Shatin, Hong Kong. 3. Department of Paediatrics and Adolescent Medicine, Queen Elizabeth Hospital, Kowloon, Hong Kong. 4. Department of Paediatrics and Adolescent Medicine, Tuen Mun Hospital, Tuen Mun, Hong Kong. 5. Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Laichikok, Hong Kong.
Abstract
INTRODUCTION: Haemoglobin Bart's hydrops fetalis syndrome was once considered a fatal condition. However, advances over the past two decades have enabled survival of affected patients. Data relating to their morbidities and outcomes will help medical specialists formulate a management plan and parental counselling. METHODS: All babies with the syndrome who survived beyond the neonatal period and were subsequently managed long-term in eight public hospitals in Hong Kong from 1 January 1996 to 31 December 2015 were included. Patient and parent characteristics, antenatal care, reasons for continuation of pregnancy, intrauterine interventions, perinatal course, presence of congenital malformations, stem-cell transplantation details, and long-term neurodevelopmental outcomes were reviewed. RESULTS: A total of nine patients were identified, of whom five were female and four male. The median follow-up duration was 7 years. All were Chinese and were homozygous for the Southeast Asian α-thalassaemia deletion. Five of the nine mothers received antenatal care at a public hospital and opted to continue the pregnancy after antenatal diagnosis and counselling. Despite intrauterine transfusions, all babies were born with respiratory depression and required intubation and mechanical ventilation during the neonatal period. Hypospadias was identified in all four male infants. Growth retardation, global developmental delay, and residual neurological deficits were noted in two-thirds of the patients. Haematopoietic stem-cell transplantation was performed in two patients, who became transfusion-independent. CONCLUSIONS: Survival of patients with Bart's hydrops fetalis syndrome is possible but not without short- and long-term complications; local epidemiology is comparable to that documented for an international registry. Detailed antenatal counselling of parents with a non-judgemental attitude and cautious optimism are imperative.
INTRODUCTION: Haemoglobin Bart's hydrops fetalis syndrome was once considered a fatal condition. However, advances over the past two decades have enabled survival of affected patients. Data relating to their morbidities and outcomes will help medical specialists formulate a management plan and parental counselling. METHODS: All babies with the syndrome who survived beyond the neonatal period and were subsequently managed long-term in eight public hospitals in Hong Kong from 1 January 1996 to 31 December 2015 were included. Patient and parent characteristics, antenatal care, reasons for continuation of pregnancy, intrauterine interventions, perinatal course, presence of congenital malformations, stem-cell transplantation details, and long-term neurodevelopmental outcomes were reviewed. RESULTS: A total of nine patients were identified, of whom five were female and four male. The median follow-up duration was 7 years. All were Chinese and were homozygous for the Southeast Asian α-thalassaemia deletion. Five of the nine mothers received antenatal care at a public hospital and opted to continue the pregnancy after antenatal diagnosis and counselling. Despite intrauterine transfusions, all babies were born with respiratory depression and required intubation and mechanical ventilation during the neonatal period. Hypospadias was identified in all four male infants. Growth retardation, global developmental delay, and residual neurological deficits were noted in two-thirds of the patients. Haematopoietic stem-cell transplantation was performed in two patients, who became transfusion-independent. CONCLUSIONS: Survival of patients with Bart's hydrops fetalis syndrome is possible but not without short- and long-term complications; local epidemiology is comparable to that documented for an international registry. Detailed antenatal counselling of parents with a non-judgemental attitude and cautious optimism are imperative.
Entities:
Keywords:
Alpha-thalassemia; Hong Kong; Hydrops fetalis; Morbidity; Thalassemia
Authors: Mullin Ho Chung Yu; Jeffrey Fong Ting Chau; Sandy Leung Kuen Au; Hei Man Lo; Kit San Yeung; Jasmine Lee Fong Fung; Christopher Chun Yu Mak; Claudia Ching Yan Chung; Kelvin Yuen Kwong Chan; Brian Hon Yin Chung; Anita Sik Yau Kan Journal: Front Genet Date: 2021-01-27 Impact factor: 4.599
Authors: Tippi C MacKenzie; Ali Amid; Michael Angastiniotis; Craig Butler; Sandra Gilbert; Juan Gonzalez; Roberta L Keller; Sandhya Kharbanda; Melanie Kirby-Allen; Barbara A Koenig; Wade Kyono; Ashutosh Lal; Billie R Lianoglou; Mary E Norton; Keith K Ogasawara; Tachjaree Panchalee; Mara Rosner; Marisa Schwab; Alexis Thompson; John S Waye; Elliott Vichinsky Journal: Blood Adv Date: 2021-12-28